t(4;11) (q21;q23) in acute myeloid leukemia-M0 following treatment [EW92 Protocol] for Ewing's sarcoma Leucemia mielóide aguda-M0 com t(4;11) (q21;q23) após tratamento para sarcoma de Ewing com o protocolo EW92

t(4;11) (q21;q23) in acute myeloid leukemia-M0 following treatment [EW92 Protocol] for Ewing's sarcoma Leucemia mielóide aguda-M0 com t(4;11) (q21;q23) após tratamento para sarcoma de Ewing com o protocolo EW92

We report on a 7-year-old girl with Ewing's Sarcoma (ES) who developed a poorly differentiated acute myeloid leukemia (AML-M0) 20 months after beginning the EW92 protocol for the treatment of the primary tumor. She received a total dose of 1500 mg of etoposide, a tumor cumulative radiation dose...

Full description

Bibliographic Details
Main Authors: Terezinha J. Marques Salles, Márcia B. Costa, Vera L. L. Morais, Romualdo J. Filho, Mario H. Magalhães, Maria L. M. Silva, Sandra M. A. Silva, Maria S. Pombo de Oliveira
Format: Article
Language:English
Published: Elsevier 2004-01-01
Series:Revista Brasileira de Hematologia e Hemoterapia
Subjects:
Leucemia mielóide aguda secundaária
translocação envolvendo a região 11q23 após uso de etoposídio
Therapy-related acute myeloid leukemia
MLL gene
Ewing's sarcoma
Topoisomerase II inhibitors
G-CSF
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842004000200010

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-84842004000200010

Similar Items